Cited by 809Angiogenesis and VEGF in CancerLymphatic System and DiseasesMathematical Biology Tumor Growth

The DOI matches its Crossref record; 270 of the 271 references it cites were found in a registry or an index.

Mechanisms of normal and tumor-derived angiogenesis

Papetti, Michael, Herman, Ira M.·2002·American Journal of Physiology-Cell Physiology

Abstract

Often those diseases most evasive to therapeutic intervention usurp the human body's own cellular machinery or deregulate normal physiological processes for propagation. Tumor-induced angiogenesis is a pathological condition that results from aberrant deployment of normal angiogenesis, an essential process in which the vascular tree is remodeled by the growth of new capillaries from preexisting vessels. Normal angiogenesis ensures that developing or healing tissues receive an adequate supply of nutrients. Within the confines of a tumor, the availability of nutrients is limited by competition among actively proliferating cells, and diffusion of metabolites is impeded by high interstitial pressure (Jain RK. Cancer Res 47: 3039–3051, 1987). As a result, tumor cells induce the formation of a new blood supply from the preexisting vasculature, and this affords tumor cells the ability to survive and propagate in a hostile environment. Because both normal and tumor-induced neovascularization fulfill the essential role of satisfying the metabolic demands of a tissue, the mechanisms by which cancer cells stimulate pathological neovascularization mimic those utilized by normal cells to foster physiological angiogenesis. This review investigates mechanisms of tumor-induced angiogenesis. The strategies used by cancer cells to develop their own blood supply are discussed in relation to those employed by normal cells during physiological angiogenesis. With an understanding of blood vessel growth in both normal and abnormal settings, we are better suited to design effective therapeutics for cancer.

Overview

Integrity signals

Registry

Crossref · 10.1152/ajpcell.00389.2001

Cites

270 of 270 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 271 references

1 of the 271 references couldn’t be matched to a known paper.

Research works printed but not linked: 32

  1. Ambs S, 1999, Cancer Res, 59, 5773
  2. Borgstrom P, 1996, Cancer Res, 56, 4032
  3. Clark RA, 1996, Am J Pathol, 148, 1407
  4. Compagni A, 2000, Cancer Res, 60, 7163
  5. Deroanne CF, 1997, Cancer Res, 57, 5590
  6. Dumont DJ, 1992, Oncogene, 7, 1471
  7. Dvorak HF, 1995, Am J Pathol, 146, 1029
  8. Esser S, 1998, J Cell Sci, 110, 2065
  9. Folkman J, 1988, Am J Pathol, 130, 393
  10. Gately S, 1996, Cancer Res, 56, 4887
  11. Goto F, 1993, Lab Invest, 69, 508
  12. Healy AM, 1992, Eur J Cell Biol, 59, 56
  13. Hughes S, 2000, Invest Ophthalmol Vis Sci, 41, 1217
  14. Jain RK., 1987, Cancer Res, 47, 3039
  15. Kitsukawa T, 1995, J Biol Chem, 121, 4309
  16. Kohn S, 1992, Lab Invest, 67, 596
  17. Korhonen J, 1994, Oncogene, 9, 395
  18. Luca M, 1997, Am J Pathol, 151, 1105
  19. Maglione D, 1993, Oncogene, 8, 925
  20. Merwin JR, 1991, Am J Pathol, 138, 37
  21. Millauer B, 1996, Cancer Res, 56, 1615
  22. Nicosia RF, 1994, Am J Pathol, 145, 1023
  23. Pajusola K, 1992, Cancer Res, 52, 5738
  24. Pierce GF, 1992, Am J Pathol, 140, 1375
  25. Senger DR, 1996, Am J Pathol, 149, 293
  26. Senger DR, 1986, Cancer Res, 46, 5629
  27. Takahashi Y, 1995, Cancer Res, 55, 3964
  28. Tanaka T, 1998, Cancer Res, 58, 3362
  29. Todaro GJ, 1990, Semin Cancer Biol, 1, 257
  30. Topp MS, 1995, Cancer Res, 55, 2173
  31. Vlodavsky I, 2000, Isr Med Assoc J, 2, 37
  32. Ziche M, 1982, J Natl Cancer Inst, 69, 475

Cited by

Sorted by citations

Items 101–200 of 808

Metadata

Authors
Papetti, M., & Herman, I. M.
Affiliations
Tufts University (US)
Venue
American Journal of Physiology-Cell Physiology
Published
2002-05-01
Volume
282
Issue
5
Pages
C947-C970
ISSN
  • 0363-6143 (ISSN-L)
  • 1522-1563
OpenAlex
W2050499474
Cited by
809
References
271
Citations by year
2026: 11 · 2025: 15 · 2024: 19 · 2023: 33 · 2022: 38 · 2021: 32 · 2020: 36 · 2019: 28 · 2018: 20 · 2017: 41 · 2016: 36 · 2015: 45 · 2014: 42 · 2013: 46 · 2012: 41
FWCI
2.10
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Physiology-Cell Physiology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01gm055110-04)
  • National Eye Institute (R01EY009033, EY09033)
  • National Institute of General Medical Sciences (GM55110)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK034928)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
  • Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
Keywords
tumor angiogenesis, physiological angiogenesis, tumor blood supply, vascular remodeling, capillary proliferation, interstitial fluid pressure, tumor microenvironment, cancer metabolism
MeSH terms
Blood Vessels, Growth Substances, Humans, Models, Cardiovascular, Neoplasms, Neovascularization, Pathologic, Proteins, Receptors, Cell Surface, Neovascularization, Physiologic, Receptor Protein-Tyrosine Kinases, Angiopoietin-2, Receptors, TIE

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review